Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction. (Q38110226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

title

Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

0 references

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Catalin F Baicu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

29 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

Journal of Cardiovascular Translational Research

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

501-515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23716130 AND SRC:MED&resulttype=core&format=json

Trends in prevalence and outcome of heart failure with preserved ejection fraction

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Role of left ventricular stiffness in heart failure with normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Emerging Biomarkers in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Membrane-associated matrix proteolysis and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

ST2: a novel biomarker for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Use of Amino-Terminal Pro–B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Primary results of the HABIT Trial (heart failure assessment with BNP in the home).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Chronic ambulatory intracardiac pressures and future heart failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Effect of nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Circulating biomarkers of collagen metabolism in cardiac diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Diastolic Stiffness of the Failing Diabetic Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12265-013-9472-1

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

21 January 2018

1 reference

12 December 2020

Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure

1 reference

12 December 2020

HFpEF: cardiovascular abnormalities not just comorbidities

1 reference

12 December 2020

Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.

1 reference

12 December 2020

Cardiomyocyte Stiffness in Diastolic Heart Failure

1 reference

12 December 2020

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

12 December 2020

Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure

1 reference

12 December 2020

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

12 December 2020

Serial measurements of plasma B-type natriuretic peptides: what do they tell us?

1 reference

12 December 2020